Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. PFSCF


Primary Symbol: LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Post by edroseon Apr 05, 2022 6:59pm
263 Views
Post# 34578569

It’s been 3 years since they wiped out retail investors then

It’s been 3 years since they wiped out retail investors then

They got them to give them an extra 38 million by doing rights offering  strange they told tsx they exhausted all options to raise money 

then they sold Isle of Man for 50 million to party they knew
then sold protein division and plasma centers ryplasim with great potential few weeks before fda approval
then sold voucher for less than it was worth 
 

During this period paid themselves huge salaries /packages  for doing what  ? Thomvest/salp could get their money back
did retail investors benefit from liquidating company  NO 
then they tell all great results that pierre laurin/scientist like Lynne Gagnon and John Moran presented us over years  where in their opinion so bad that they stopped research on 4050 because of their small study showed pk data was so bad it was not worth continuin

so who will the judge believe lmnl new management and their scientist like Moira Daniels who replaced renowned Lynne gagnon or will the judge believe prometics scientists doctor Gagnon and her team,john moran and pierre laurin
look at all the positive findings /results they showed us over past years BEFORE THOMVESTwiped retail investors  both plasma division and small molecule division    They surely didn't invent the data they presented to investors 

<< Previous
Bullboard Posts
Next >>